Insider Trading & Ownership - Column Group IV GP LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Column Group IV GP LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-15
Purchase
2023-11-17
4:30 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:34 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:37 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-03
Purchase
2022-11-07
4:20 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:55 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
5:05 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
984,161$13.5$13,286,17418,143,374
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:44 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
34,200$13.03$445,73918,110,897
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
153,806$13.46$2,069,66718,109,768
(Indirect
Direct)
View
2022-05-26
Purchase
2022-05-31
5:02 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
22,911$13.49$309,03518,104,692
(Indirect
Direct)
View
2022-05-25
Purchase
2022-05-27
4:29 pm
RAPT Therapeutics Inc.RAPTCOLUMN GROUP II LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
10% Owner
1,900$12.45$23,6643,189,178
(Indirect
Direct)
View
2022-05-24
Purchase
2022-05-26
4:13 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
61,120$13.42$819,94818,103,936
(Indirect
Direct)
View
2022-05-23
Purchase
2022-05-25
4:20 pm
RAPT Therapeutics Inc.RAPTCOLUMN GROUP II LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
10% Owner
26,550$12.19$323,7453,189,115
(Indirect
Direct)
View
2022-05-19
Purchase
2022-05-23
4:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
39,700$13.36$530,45418,101,919
(Indirect
Direct)
View
2022-05-17
Purchase
2022-05-19
4:39 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
151,699$13.33$2,022,00418,100,609
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-17
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
162,531$2.6327$427,89118,095,603
(Indirect
Direct)
View
2022-05-11
Purchase
2022-05-13
5:32 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
166,350$11.43$1,902,03218,090,240
(Indirect
Direct)
View
2022-05-10
Purchase
2022-05-12
5:29 pm
RAPT Therapeutics Inc.RAPTCOLUMN GROUP II LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
10% Owner
1,250,000$10.67$13,339,3753,188,239
(Indirect
Direct)
View
2022-05-09
Purchase
2022-05-11
6:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
114,440$10.95$1,252,98218,084,750
(Indirect
Direct)
View
2022-01-24
Purchase
2022-01-26
7:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
849,701$0$018,080,973
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-05
Other
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
1,000$02,000
(Indirect)
View
2024-04-05
Disposition
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
20,344,505$02,000
(Indirect)
View